Mechanisms of long COVID: An updated review

[1]  Guohui Fan,et al.  6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2023, The Lancet.

[2]  S. Ross.  Long COVID and Mitochondrial Dysfunction. , 2023, Holistic nursing practice.

[3]  David H. Brann,et al.  Persistent post–COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium , 2022, Science Translational Medicine.

[4]  A. Kiadaliri,et al.  Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants , 2022, Nature Communications.

[5]  G. Plazzi,et al.  The role of sleep and dreams in long‐COVID , 2022, Journal of sleep research.

[6]  M. Maniscalco,et al.  Clinical assessment of endothelial function in convalescent COVID-19 patients: a meta-analysis with meta-regressions , 2022, Annals of medicine.

[7]  S. Ng,et al.  Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome , 2022, Nature Communications.

[8]  A. Verger,et al.  Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  K. Melmed,et al.  Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization , 2022, Journal of the Neurological Sciences.

[10]  J. Dahl,et al.  Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection , 2022, International Journal of Infectious Diseases.

[11]  D. Buonsenso,et al.  Extended coagulation profile of children with Long Covid: a prospective study , 2022, Scientific Reports.

[12]  L. Wieler,et al.  Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany , 2022, PLoS medicine.

[13]  P. Spieth,et al.  Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome , 2022, Scientific Reports.

[14]  B. Bourrion,et al.  Quality of Life in COVID-19 Outpatients: A Long-Term Follow-Up Study , 2022, Journal of clinical medicine.

[15]  B. Giusti,et al.  Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes , 2022, Viruses.

[16]  M. Reed,et al.  COVID-19 as a Risk Factor for Alzheimer's Disease. , 2022, Journal of Alzheimer's disease : JAD.

[17]  I. Petrache,et al.  Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC) , 2022, Metabolites.

[18]  Oscar J. Pellicer-Valero,et al.  Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors , 2022, Genes.

[19]  F. Bozza,et al.  Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors , 2022, Circulation research.

[20]  P. Claret,et al.  Low perforin expression in CD8+ T lymphocytes during the acute phase of severe SARS-CoV-2 infection predicts long COVID , 2022, Frontiers in Immunology.

[21]  K. Klouche,et al.  Persistence of neutrophil extracellular traps and anticardiolipin auto‐antibodies in post‐acute phase COVID‐19 patients , 2022, Journal of medical virology.

[22]  D. Seidel,et al.  The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19 , 2022, Frontiers in Cardiovascular Medicine.

[23]  Zheng Zhang,et al.  Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study , 2022, Emerging microbes & infections.

[24]  Shannon Seney,et al.  Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism , 2022, Molecular Medicine.

[25]  A. Simonetti,et al.  Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study , 2022, PloS one.

[26]  Hong-Gang Li,et al.  Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-months recovery of COVID-19 , 2022, Frontiers in Cell and Developmental Biology.

[27]  Abhinava Gupta,et al.  Delayed catastrophic thrombotic events in post-acute COVID-19 , 2022, Thrombosis research.

[28]  A. Caroli,et al.  Structural and Functional Pulmonary Assessment in Severe COVID-19 Survivors at 12 Months after Discharge , 2022, Tomography.

[29]  D. Güven,et al.  Clinical and laboratory predictors of long-COVID in children: a single center retrospective study. , 2022, European review for medical and pharmacological sciences.

[30]  D. Abecasis,et al.  Characteristics of long COVID among older adults: a cross-sectional study , 2022, International Journal of Infectious Diseases.

[31]  D. Bahia,et al.  Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: New clues to long-term cognitive disorders , 2022, Frontiers in Cellular and Infection Microbiology.

[32]  Xia Li,et al.  Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study , 2022, eClinicalMedicine.

[33]  W. Lukiw,et al.  SARS-CoV-2, long COVID, prion disease and neurodegeneration , 2022, Frontiers in Neuroscience.

[34]  J. Derisi,et al.  Low Prevalence of Interferon-α Autoantibodies in People Experiencing Long COVID Symptoms , 2022, The Journal of infectious diseases.

[35]  N. Opel,et al.  Larger gray matter volumes in neuropsychiatric long-COVID syndrome , 2022, Psychiatry Research.

[36]  Z. Gai,et al.  Hypertension is still a moving target in the context of COVID‐19 and post‐acute COVID‐19 syndrome , 2022, Journal of medical virology.

[37]  M. Lau,et al.  Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID , 2022, Frontiers in Immunology.

[38]  S. Ong,et al.  Long COVID-19 and the heart: is cardiac mitochondria the missing link? , 2022, Antioxidants & redox signaling.

[39]  B. Trimarco,et al.  Targeting endothelial dysfunction and oxidative stress in Long-COVID , 2022, Pharmacological Research.

[40]  T. Palaga,et al.  Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery , 2022, Journal of Microbiology, Immunology and Infection.

[41]  Leah Shaffer.  Lots of long COVID treatment leads, but few are proven , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Sfikakis,et al.  Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID , 2022, Clinical Immunology.

[43]  P. Bickford,et al.  SARS-CoV-2 infection increases the gene expression profile for Alzheimer’s disease risk , 2022, Molecular Therapy - Methods & Clinical Development.

[44]  C. Kirschbaum.  What to do now that hypocortisol appears to be a predominant sign of long COVID? , 2022, Psychoneuroendocrinology.

[45]  S. Urbani,et al.  The Role of Obesity, Body Composition, and Nutrition in COVID-19 Pandemia: A Narrative Review , 2022, Nutrients.

[46]  R. Cox,et al.  Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  E. Corruble,et al.  Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

[48]  E. Puchhammer-Stöckl,et al.  Association between Epstein‐Barr‐Virus reactivation and development of Long‐COVID fatigue , 2022, Allergy.

[49]  G. Evers,et al.  Persistent capillary rarefication in long COVID syndrome , 2022, Angiogenesis.

[50]  F. Johnston,et al.  Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes , 2022, Frontiers in Immunology.

[51]  Benjamin Kye Jyn Tan,et al.  Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves , 2022, BMJ.

[52]  J. Kopp,et al.  RAGE pathway activation and function in chronic kidney disease and COVID-19 , 2022, Frontiers in Medicine.

[53]  S. Ng,et al.  Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance , 2022, Gut.

[54]  S. Saydah,et al.  Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[55]  J. Rosmalen,et al.  Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study , 2022, The Lancet.

[56]  M. Wills,et al.  Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  A. Mastalerz-Migas,et al.  Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study , 2022, Viruses.

[58]  C. Scheibenbogen,et al.  Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro , 2022, Cells.

[59]  J. Laurence,et al.  Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches , 2022, The Journal of clinical investigation.

[60]  C. Camponeschi,et al.  Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children , 2022, Journal of clinical medicine.

[61]  G. Gkoutos,et al.  Symptoms and risk factors for long COVID in non-hospitalized adults , 2022, Nature Medicine.

[62]  J. Dunne,et al.  Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction , 2022, Journal of Thrombosis and Haemostasis.

[63]  B. Brundel,et al.  Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases , 2022, Cardiovascular research.

[64]  M. Peluso,et al.  Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID , 2022, medRxiv : the preprint server for health sciences.

[65]  Huy Q. Dinh,et al.  Single‐cell immune profiling reveals long‐term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID‐19 hospitalization , 2022, Journal of leukocyte biology.

[66]  D. Agrawal,et al.  Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics , 2022, Expert Review of Clinical Immunology.

[67]  Winnie A Mar,et al.  Musculoskeletal Manifestations of COVID-19: Currently Described Clinical Symptoms and Multimodality Imaging Findings , 2022, Radiographics : a review publication of the Radiological Society of North America, Inc.

[68]  T. Sathish,et al.  Persistence of new-onset diabetes in the post-acute phase of COVID-19 , 2022, International Journal of Diabetes in Developing Countries.

[69]  O. Blagova,et al.  Chronic biopsy proven post‐COVID myoendocarditis with SARS‐Cov‐2 persistence and high level of antiheart antibodies , 2022, Clinical cardiology.

[70]  Ke Zhang,et al.  Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor ACE2 That Is Potentially Involved in Long COVID , 2022, Frontiers in genetics.

[71]  R. Boellaard,et al.  2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[72]  R. Xu,et al.  Revealing the mystery of persistent smell loss in Long COVID patients , 2022, International journal of biological sciences.

[73]  N. Marx,et al.  Diaphragm dysfunction as a potential determinant of dyspnea on exertion in patients 1 year after COVID-19-related ARDS , 2022, Respiratory Research.

[74]  J. Książyk,et al.  Long-COVID in immunocompromised children , 2022, European Journal of Pediatrics.

[75]  D. Buonsenso,et al.  Orbito-Frontal Cortex Hypometabolism in Children With Post-COVID Condition (Long COVID): A Preliminary Experience , 2022, The Pediatric infectious disease journal.

[76]  M.R.Q. Davies.  Long covid patients travel abroad for expensive and experimental “blood washing” , 2022, BMJ.

[77]  R. Khouri,et al.  Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms , 2022, Frontiers in Endocrinology.

[78]  T. Tung,et al.  The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: A longitudinal cohort study , 2022, International Immunopharmacology.

[79]  Ruth R. Montgomery,et al.  Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study , 2022, eBioMedicine.

[80]  B. Trimarco,et al.  Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey , 2022, Pharmacological Research.

[81]  P. Taub,et al.  Postural orthostatic tachycardia syndrome as a sequela of COVID-19 , 2022, Heart Rhythm.

[82]  T. Iwashyna,et al.  Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System , 2022, JAMA network open.

[83]  A. Caicedo,et al.  Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: Positron emission tomography (PET) scan , 2022, European Neuropsychopharmacology.

[84]  M. P. Borrelli,et al.  The long haul COVID-19 arterial thrombosis , 2022, Thrombosis Research.

[85]  D. F. Henriques,et al.  Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome , 2022, Frontiers in Cellular and Infection Microbiology.

[86]  P. Hansbro,et al.  Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β , 2022, Frontiers in Immunology.

[87]  K. Bhaskaran,et al.  Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records , 2022, Nature Communications.

[88]  Oscar J. Pellicer-Valero,et al.  Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant , 2022, Pathogens.

[89]  J. Wise.  Covid-19: Long covid risk is lower with omicron than delta, researchers find , 2022, BMJ.

[90]  G. Alter,et al.  Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae , 2022, medRxiv.

[91]  W. Wierzba,et al.  Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection , 2022, Frontiers in Immunology.

[92]  A. Borczuk,et al.  SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery , 2022, Science Translational Medicine.

[93]  Edward A. Lee,et al.  High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples , 2022, Journal of Molecular and Cellular Cardiology.

[94]  Maren J H Rytter.  Difficult questions about long COVID in children , 2022, The Lancet Child & Adolescent Health.

[95]  D. Perl,et al.  Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation , 2022, Cell.

[96]  C. Hopkins,et al.  The COVANOS trial - insight into post-COVID olfactory dysfunction and the role of smell training. , 2022, Rhinology.

[97]  C. Steves,et al.  Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 , 2022, The Lancet.

[98]  F. Beuschlein,et al.  Is there a role for the adrenal glands in long COVID? , 2022, Nature Reviews Endocrinology.

[99]  Boli Zhang,et al.  The Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan , 2022, Journal of clinical medicine.

[100]  Z. Al-Aly,et al.  Long COVID after breakthrough SARS-CoV-2 infection , 2022, Nature Medicine.

[101]  C. Maertens de Noordhout,et al.  Pathophysiology and mechanism of long COVID: a comprehensive review , 2022, Annals of medicine.

[102]  N. Ohmagari,et al.  Post COVID-19 condition of the Omicron variant of SARS-CoV-2 , 2022, Journal of Infection and Chemotherapy.

[103]  J. Sparks,et al.  DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study , 2022, Seminars in Arthritis and Rheumatism.

[104]  M. Nolano,et al.  Impaired Vagal Activity in Long-COVID-19 Patients , 2022, Viruses.

[105]  Ye-ming Wang,et al.  Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study , 2022, The Lancet Respiratory Medicine.

[106]  Laura Schneider,et al.  Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults , 2022, Frontiers in Neurology.

[107]  M. Esteller,et al.  Accelerated biological aging in COVID-19 patients , 2022, Nature Communications.

[108]  W. Baumgärtner,et al.  Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model , 2022, eBioMedicine.

[109]  J. Bauer,et al.  Malnutrition and Sarcopenia in COVID-19 Survivors , 2022, Clinics in Geriatric Medicine.

[110]  M. I. Girón-Pérez,et al.  Loss of mitochondrial membrane potential (ΔΨ m) in leucocytes as post‐COVID‐19 sequelae , 2022, Journal of leukocyte biology.

[111]  M. Maniscalco,et al.  Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target , 2022, Biomedicines.

[112]  T. Luedde,et al.  Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients , 2022, Infection.

[113]  V. Planelles,et al.  Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers , 2022, Frontiers in Immunology.

[114]  Amitava Banerjee,et al.  Long COVID and cardiovascular disease: a learning health system approach , 2022, Nature Reviews Cardiology.

[115]  M. Isola,et al.  Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients , 2022, Clinical Microbiology and Infection.

[116]  F. Paul,et al.  Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) , 2022, Journal of translational medicine.

[117]  G. Foti,et al.  One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study , 2022, Respiratory Research.

[118]  M. Merad,et al.  The immunology and immunopathology of COVID-19 , 2022, Science.

[119]  Paloma Martin,et al.  Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19 , 2022, BMC Infectious Diseases.

[120]  J. Knight,et al.  SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study , 2022, The Lancet Microbe.

[121]  C. Prado,et al.  The Impact of Long COVID-19 on Muscle Health , 2022, Clinics in Geriatric Medicine.

[122]  Yan Xie,et al.  Risks and burdens of incident diabetes in long COVID: a cohort study , 2022, The Lancet Diabetes & Endocrinology.

[123]  G. Filippatos,et al.  Myocardial work and vascular dysfunction are partially improved at 12 months after COVID‐19 infection , 2022, European journal of heart failure.

[124]  H. Moch,et al.  Long-Term Persisting SARS-CoV-2 RNA and Pathological Findings: Lessons Learnt From a Series of 35 COVID-19 Autopsies , 2022, Frontiers in Medicine.

[125]  A. Pozzi.  COVID-19 and Mitochondrial Non-Coding RNAs: New Insights From Published Data , 2022, Frontiers in Physiology.

[126]  J. D. de Jesus,et al.  Trace element homeostasis in the neurological system after SARS-CoV-2 infection: Insight into potential biochemical mechanisms , 2022, Journal of Trace Elements in Medicine and Biology.

[127]  I. Heyman,et al.  Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study , 2022, The Lancet Child & Adolescent Health.

[128]  H. Bundgaard,et al.  Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study , 2022, The Lancet Child & Adolescent Health.

[129]  Mark S. Anderson,et al.  Human genetic and immunological determinants of critical COVID-19 pneumonia , 2022, Nature.

[130]  G. Tetz,et al.  Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2 , 2022, Microorganisms.

[131]  K. Stavem,et al.  Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID‐19 , 2022, Journal of the American Heart Association.

[132]  K. Telle,et al.  Healthcare use in 700 000 children and adolescents for six months after covid-19: before and after register based cohort study , 2022, BMJ.

[133]  S. Ellermann-Eriksen,et al.  Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study , 2022, European Journal of Pediatrics.

[134]  P. Shah,et al.  Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease , 2022, Immunity.

[135]  A. Boner,et al.  Long-term outcomes of pediatric infections: from traditional infectious diseases to long covid , 2022, Future microbiology.

[136]  Maria Papadopoulou,et al.  Neurological manifestations of long-COVID syndrome: a narrative review , 2022, Therapeutic advances in chronic disease.

[137]  Ye-ming Wang,et al.  Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study , 2021, Frontiers in Immunology.

[138]  K. Kaila,et al.  APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study , 2021, Acta neuropathologica communications.

[139]  Ivan G. Costa,et al.  SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids , 2021, Cell Stem Cell.

[140]  Bradford A. Youngblood,et al.  Mast cell activation is associated with post‐acute COVID‐19 syndrome , 2021, Allergy.

[141]  Shin Nagayama,et al.  Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit , 2021, Scientific Reports.

[142]  K. Kalantar-Zadeh,et al.  Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis , 2021, Current opinion in nephrology and hypertension.

[143]  N. Zachara,et al.  Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage , 2021, Vascular Pharmacology.

[144]  A. Aguzzi,et al.  COVID-19 targets human adrenal glands , 2021, The Lancet Diabetes & Endocrinology.

[145]  M. Peluso,et al.  Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[146]  C. Fernández‐de‐las‐Peñas,et al.  Diabetes and the Risk of Long-term Post-COVID Symptoms , 2021, Diabetes.

[147]  A. Walters,et al.  Mast cell activation symptoms are prevalent in Long-COVID , 2021, International Journal of Infectious Diseases.

[148]  A. Coppola,et al.  Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis , 2021, EClinicalMedicine.

[149]  Benjamin Bowe,et al.  Kidney Outcomes in Long COVID , 2021, Journal of the American Society of Nephrology : JASN.

[150]  U. Tirelli,et al.  Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients. , 2021, European review for medical and pharmacological sciences.

[151]  Mark S. Anderson,et al.  Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 , 2021, Science Translational Medicine.

[152]  Mark S. Anderson,et al.  Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths , 2021, Science Immunology.

[153]  T. Renné,et al.  Persistent endotheliopathy in the pathogenesis of long COVID syndrome , 2021, Journal of Thrombosis and Haemostasis.

[154]  Ting Yu,et al.  1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study , 2021, The Lancet.

[155]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[156]  F. Dioguardi,et al.  Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications , 2021, Frontiers in Medicine.

[157]  U. Merle,et al.  Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[158]  M. VanElzakker,et al.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms , 2021, Frontiers in Microbiology.

[159]  D. Kell,et al.  Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin , 2021, Cardiovascular Diabetology.

[160]  M. Dimopoulos,et al.  Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review , 2021, Journal of Infection.

[161]  M. Cecconi,et al.  Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[162]  S. Yong.  Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis , 2021, ACS chemical neuroscience.

[163]  D. Raoult,et al.  18F-FDG brain PET hypometabolism in patients with long COVID , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[164]  E. Playford,et al.  Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline , 2021, BMJ.

[165]  P. Venkatesan.  NICE guideline on long COVID , 2021, The Lancet Respiratory Medicine.

[166]  R. Kream,et al.  Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce ‘Brain Fog’ and Results in Behavioral Changes that Favor Viral Survival , 2021, Medical science monitor : international medical journal of experimental and clinical research.

[167]  P. Cohen,et al.  Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples , 2021, Scientific Reports.

[168]  S. Jameson,et al.  T Cell Memory: Understanding COVID-19 , 2020, Immunity.

[169]  J. Guevara-Coto,et al.  Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning , 2020, bioRxiv.

[170]  Elizabeth B White,et al.  Diverse Functional Autoantibodies in Patients with COVID-19 , 2020, Nature.

[171]  P. Zimmet,et al.  Proportion of newly diagnosed diabetes in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Diabetes, obesity & metabolism.

[172]  Aaron J. Johnson,et al.  Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia , 2020, Science Immunology.

[173]  T. Lazzarotto,et al.  Brain ischemic injury in COVID‐19‐infected patients: a series of 10 post‐mortem cases , 2020, Brain pathology.

[174]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[175]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[176]  F. Neff,et al.  Early evidence of pronounced brain involvement in fatal COVID-19 outcomes , 2020, The Lancet.

[177]  P. Klenerman,et al.  Local heroes or villains: tissue-resident memory T cells in human health and disease , 2020, Cellular & Molecular Immunology.

[178]  D. Chambers,et al.  Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: a systematic scoping review of multiple predictor studies , 2007, Psychological Medicine.